135 related articles for article (PubMed ID: 15854763)
1. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
Blanco Y; Saiz A; Costa M; Torres-Peraza JF; Carreras E; Alberch J; Jaraquemada D; Graus F
Neurosci Lett; 2005 May 20-27; 380(1-2):122-6. PubMed ID: 15854763
[TBL] [Abstract][Full Text] [Related]
2. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P
Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900
[TBL] [Abstract][Full Text] [Related]
3. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.
Roccatagliata L; Rocca M; Valsasina P; Bonzano L; Sormani M; Saccardi R; Mancardi G; Filippi M;
Mult Scler; 2007 Sep; 13(8):1068-70. PubMed ID: 17468445
[TBL] [Abstract][Full Text] [Related]
4. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Tamaño-Blanco M; Abdelrahman N; Badgett D; Durfee J; Hussein S; Feichter J; Patrick K; Benedict R; Ramanathan M
J Neuroimmunol; 2007 Aug; 188(1-2):167-74. PubMed ID: 17602759
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
[TBL] [Abstract][Full Text] [Related]
6. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
Azoulay D; Urshansky N; Karni A
J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
[TBL] [Abstract][Full Text] [Related]
8. Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis.
Blanco Y; Saiz A; Carreras E; Graus F
J Neuroimmunol; 2004 Aug; 153(1-2):190-4. PubMed ID: 15265677
[TBL] [Abstract][Full Text] [Related]
9. Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients.
Patanella AK; Zinno M; Quaranta D; Nociti V; Frisullo G; Gainotti G; Tonali PA; Batocchi AP; Marra C
J Neurosci Res; 2010 Apr; 88(5):1106-12. PubMed ID: 19885866
[TBL] [Abstract][Full Text] [Related]
10. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
11. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.
Zivadinov R; Weinstock-Guttman B; Benedict R; Tamaño-Blanco M; Hussein S; Abdelrahman N; Durfee J; Ramanathan M
Hum Mol Genet; 2007 Nov; 16(22):2659-68. PubMed ID: 17656372
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
[TBL] [Abstract][Full Text] [Related]
16. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
[TBL] [Abstract][Full Text] [Related]
18. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder.
Gustafsson G; Lira CM; Johansson J; Wisén A; Wohlfart B; Ekman R; Westrin A
Psychiatry Res; 2009 Oct; 169(3):244-8. PubMed ID: 19729204
[TBL] [Abstract][Full Text] [Related]
19. Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients.
Mercader JM; Fernández-Aranda F; Gratacòs M; Ribasés M; Badía A; Villarejo C; Solano R; González JR; Vallejo J; Estivill X
Neuropsychobiology; 2007; 56(4):185-90. PubMed ID: 18337636
[TBL] [Abstract][Full Text] [Related]
20. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
